Form 4 for IRMD IRADIMED CORP
Accepted 2025-12-12 00:00:00 ET · period of report 2025-12-11 · accession 0001253497-25-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-12 | 2025-12-11 | IRMD | GLENN JOHN | CFO | F - Tax | $97.38 | -714 | 8,460 | -8% | -$69.5K |
| DM | 2025-12-12 | 2025-12-11 | IRMD | GLENN JOHN | CFO | S - Sale+OE | $97.29 | -15.0K | 7,362 | -67% | -$1.46M |
| D | 2025-12-12 | 2025-12-11 | IRMD | GLENN JOHN | CFO | M - OptEx | — | +1,812 | 9,174 | +25% | — |
| D | 2025-12-12 | 2025-12-11 | IRMD | GLENN JOHN | CFO | M - OptEx | $0.00 | -1,812 | 3,624 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-11 | F | D | 714 | $97.38 | 8,460 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-11 | S | D | 14,468 | $97.26 | 7,894 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $97.00 to $97.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-12-11 | S | D | 532 | $98.09 | 7,362 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-11 | M | A | 1,812 | — | 9,174 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 5 | Derivative | Restricted Stock Units | 2025-12-11 | M | D | 1,812 | $0.00 | 3,624 | D | — · — to — | 1,812 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F3) The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. |